je.st
news
Tag: hcv
Merck Demands $3 Billion In HCV Royalties From Gilead
2016-03-11 20:20:18| Biotech - Topix.net
Merck wants to Bogart a $3B royalty payment equal to 10% of the $31.7B Gilead has made from HCV sales. Gilead has had a target on its back from regulators, competitors and politicians ever since its blockbuster HCV regimen hit the market.
Tags: billion
demands
merck
royalties
Premarket Biotech Digest: Tracking Gilead HCV Sales, Shire-Baxalta Deal, AstraZeneca Deal
2015-12-17 17:08:44| Biotech - Topix.net
The current consensus forecast for fourth quarter HCV sales is $2.81 billion. In the third quarter, U.S. HCV sales had totaled $3.23 billion.
Tags: sales
deal
tracking
digest
Premarket Biotech Digest: Gilead And HCV Drug Pricing, Relypsa Rumors, Amgen-Merck Collaboration
2015-12-07 17:45:48| Biotech - Topix.net
Our regular management interview will be held on our subscription panel today at 11am EST with Dr Todd Brady, MD, PhD, CEO of Aldeyra . Please buy a discounted subscription to participate in the panel discussion, and other discussions held regularly for subscribers.
Tags: drug
pricing
collaboration
digest
Gilead's HCV Sales May Have Peaked
2015-11-30 16:10:15| Biotech - Topix.net
A potential rate hike and a disappointing Q4 earnings season could cause a pullback in broader markets, taking GILD with it. Gilead has been a tremendous growth story ever since its HCV drug, Sovaldi/Harvoni, hit the market.
Tags: sales
peaked
hcv
gileads
Premarket Biotech Digest: Gilead U.S. HCV Sales, Sanofi's Animal...
2015-11-30 16:10:14| Biotech - Topix.net
Click this link to find out how much you can save). . Gilead Sciences' HCV sales in the U.S. look solid based on prescription data for the first six weeks of the fourth quarter.
Tags: sales
animal
digest
biotech